AI-generated summary
This review examines the use of photobiomodulation (PBM) in patients with oral graft-versus-host disease, summarizing its reported biological mechanisms and suggested parameters. The authors report that PBM has been associated with symptom relief and improved function in oral GVHD and recommend it as an adjuvant therapy. They also state that further research is needed on optimal devices, parameters and possible complications.
- Who or what was studied
- Patients with oral graft-versus-host disease
- Limits stated in the abstract
- The abstract does not report the number of studies reviewed, and the authors state that further research is required on devices, parameters and complications.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.